Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
In this JAMA Original Investigation, the researchers studied 19,529 patients with Medicare coverage who initiated first systemic therapy for advanced non–small cell lung cancer (NSCLC) using 1 of 4 regimens of checkpoint inhibitor immunotherapy, cytotoxic chemotherapy, and combined chemoimmunotherapy. The goal? To gauge the uptake and effectiveness of immunotherapy among older patients outside clinical trials.
Geriatrics June 2nd 2021
We touched on the “non-medical” books that should be on every doctor’s list in a previous newsletter; in this article, we’re directing you to the most important books on pandemics throughout history. As COVID-19 slows down in the US – but still rages on in other countries – it’s important to prepare yourself for what comes next and gather insights to best combat the unknown if and when it does arrive.
Allergy & Immunology May 26th 2021
Healthgrades for Professionals
As millions of Americans get vaccinated, you may be being presented with many questions about what’s next and whether your patients – and you! – are going to need vaccine passports to begin traveling again. Educate yourself and your patients with these five pieces of knowledge on digital health and vaccine passport apps. Whether the interest is international or domestic travel, the information applies.
Allergy & Immunology May 25th 2021
From new scams like unproven COVID-19 treatments to the returns-like-a-bad-penny “Diabetes Fast Fixes,” health product swindles are unfortunately part of the world we live in. The too-good-to-be-true claims allure many patients suffering from debilitating conditions, and at best, it may be just a waste of money. At worst, though, some of these products could cause serious problems and possibly even death.
Allergy & Immunology May 19th 2021
This article dives into information and the causes of five drug-induced diseases (DIDs) including hyponatremia/SIADH, pulmonary disease, GI bleeding, QT prolongation/Torsades de pointes, and hypoglycemia. Because research reviewed by the FDA for drug approval does not always include DIDs, it is the physician’s responsibility to monitor for DIDs and think twice about prescribing agents that could lead to DIDs.
This podcast/article on KevinMD.com by Syad Nishat, a partner at the Wall Street Alliance Group, offers tips and advice for the physician on estate planning, which is one of the most neglected aspects of financial planning. However, its complexity and unpredictability shouldn’t stop you from talking to a financial advisor to best prepare yourself and your family for the unexpected.
Allergy & Immunology May 12th 2021